drugset / Trial / NCT00061867

Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer

NCT00061867 ↗

Phase 1 Completed Imunon
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as liposomal doxorubicin, use different ways to stop tumor cells from dividing so they stop growing or die. Microwave thermotherapy kills tumor cells by heating them to several degrees above body temperature. Combining liposomal doxorubicin with microwave thermotherapy may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of liposomal doxorubicin when given together with microwave thermotherapy in treating patients with prostate cancer.

Timeline

Start
2003-03
Primary completion
—
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified — Intravenous

Indications